Related Experiment Video
Updated: May 26, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Blastic plasmacytoid dendritic cell neoplasm on the scalp
Sawako Fukushi1, Fujimura Taku, Setsuya Aiba
1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Insights
Blastic plasmacytoid dendritic cell neoplasm is a rare cancer. This case highlights a rapidly progressing presentation in an elderly Japanese woman, emphasizing the need for prompt diagnosis and treatment.
Area of Science:
- Hematology
- Oncology
- Dermatopathology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy with a predilection for skin involvement.
- Early diagnosis and effective treatment strategies are crucial for improving patient outcomes in BPDCN.
Observation:
- A 75-year-old Japanese woman presented with disseminated, firm nodules and purpura on her scalp.
- Histopathological examination revealed dense infiltration of atypical large lymphocytes in the dermis and subcutaneous tissue.
- Immunohistochemical analysis identified these cells as CD4, CD56, and vimentin positive.
Findings:
- The patient was diagnosed with blastic plasmacytoid dendritic cell neoplasm.
- Despite intensive chemotherapy, the disease progressed rapidly.
Implications:
- This case underscores the aggressive nature of BPDCN, even in elderly patients.
- Further research into novel therapeutic approaches for BPDCN is warranted to improve survival rates.
Abstract:
We describe a 75-year-old Japanese woman with blastic plasmacytoid dendritic cell neoplasm. On her first visit, there were multiple areas of disseminated, elastic hard nodules with multicentric purpura on her scalp. Histopathologically, there were atypical large lymphocytes densely infiltrated through the upper dermis to subcutaneous tissue. Immunohistochemical staining revealed that these infiltrated lymphocytes were CD4, CD56 and vimentin positive. Although we administered several courses of intensive chemotherapy soon after the diagnosis, the patient died 5 months after the first visit.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation